CROTTI, LIA
 Distribuzione geografica
Continente #
NA - Nord America 3.249
EU - Europa 2.399
AS - Asia 1.768
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 3
AF - Africa 1
Totale 7.440
Nazione #
US - Stati Uniti d'America 3.189
CN - Cina 1.564
IE - Irlanda 797
UA - Ucraina 386
FI - Finlandia 330
IT - Italia 329
DE - Germania 249
SG - Singapore 163
GB - Regno Unito 102
SE - Svezia 94
CA - Canada 58
FR - Francia 39
BE - Belgio 34
IN - India 16
JP - Giappone 14
RU - Federazione Russa 10
AU - Australia 9
EU - Europa 6
NL - Olanda 6
IR - Iran 5
HK - Hong Kong 4
NZ - Nuova Zelanda 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
LU - Lussemburgo 3
BR - Brasile 2
ES - Italia 2
GR - Grecia 2
LT - Lituania 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
CR - Costa Rica 1
IQ - Iraq 1
KR - Corea 1
MD - Moldavia 1
MU - Mauritius 1
MX - Messico 1
NO - Norvegia 1
PE - Perù 1
Totale 7.440
Città #
Dublin 794
Chandler 708
Jacksonville 492
Nanjing 434
Ashburn 250
Boardman 199
Nanchang 170
Beijing 162
Wilmington 145
Princeton 140
Lawrence 138
Shenyang 134
Singapore 120
Changsha 119
Hebei 119
Ann Arbor 118
Helsinki 118
Jiaxing 108
Medford 97
Milan 86
Hangzhou 66
Shanghai 65
Tianjin 62
Pavia 51
New York 42
Woodbridge 36
Toronto 35
Brussels 29
Norwalk 27
Verona 23
Fairfield 21
Seattle 21
Houston 19
Ottawa 19
Los Angeles 18
Kunming 15
Falls Church 14
Tokyo 14
Trieste 13
Bergamo 12
Des Moines 12
Falkenstein 11
Pune 10
Zhengzhou 9
Berlin 8
Piscataway 8
Rochester 8
Florence 7
Guangzhou 7
Jinan 7
Orange 7
Auburn Hills 6
Liverpool 6
Lodi 6
Modena 6
San Francisco 6
Travaco Siccomario 6
Antwerp 5
Dearborn 5
Monza 5
Ningbo 5
Saint-herblain 5
Washington 5
Zola Predosa 5
Catania 4
Chicago 4
Como 4
Dallas 4
Dresden 4
Frankfurt am Main 4
Fuzhou 4
Naples 4
Nuremberg 4
Padova 4
Saint Petersburg 4
Tappahannock 4
Van Nuys 4
Brisbane 3
Cork 3
London 3
Melbourne 3
Nutley 3
Pontassieve 3
Saluzzo 3
Turin 3
Amsterdam 2
Athens 2
Auckland 2
Bologna 2
Borås 2
Boston 2
Brembate di Sopra 2
Brno 2
Cambridge 2
Changchun 2
Copenhagen 2
Dunedin 2
Esch-sur-Alzette 2
Fiesole 2
Genoa 2
Totale 5.524
Nome #
Mapping the human genetic architecture of COVID-19 163
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. 103
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis. 96
A first update on mapping the human genetic architecture of COVID-19 92
The LQT2 KCNH2-Q376Q splicing muation: functional characterization, molecular correction and therapeutic implication. 89
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. 86
Gene symbol: KCNH2 85
AKAP9 is a genetic modifier of congenuital Long-QT Syndrome type 1 83
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. 83
Spectrum and prevalence of mutations involving BrS1-12 susceptibility genes in a cohort of unrelated patients referred for Brugada Syndrome genetic testing: implications for genetic testing. 82
FGF12 is a candidate Brugada syndrome locus. 82
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1. 77
Individual autonomic profile contributes to the risk for life-threatening arrhythmias among KCNQ1-A341V mutation carriers 76
The ICD for the long QT syndrome: which indications, complications, and results? 76
Novel human pathological mutations. Gene symbol: SCN5A. Disease: Brugada Syndrome. 75
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 75
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome. 73
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 73
Electrocardiographic and genetic screening for long QT syndrome: results from a prospective study on 44,596 neonates. 72
Long QT and short QT syndromes. 71
All LQT3 patients need an ICD. True or false? 70
QT lungo, sindrome del 67
Cardiac sodium channel dysfunction in sudden infant death syndrome. 67
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. 67
Idiopathic Ventricular Fibrillation. 67
Congenital long QT and short QT syndromes 67
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. 66
Inherited cardiac arrhythmia syndrome. Role of potassium channels 65
Cardiac potassium channel dysfunction in sudden infant death syndrome. 65
Prevalence of the congenital long-QT syndrome. 65
Can a message from the dead save lives? 64
Arrhythmogenic disorders of genetic origin. Long QT Syndrome: from genetics to management. 63
A comprehensive electrocardiographic, molecular, and echocardiographic study of Brugada syndrome: validation of the 2013 diagnostic criteria. 63
Gene symbol: SCN5A 62
Two cases of sudden unexpected death in epilepsy in a GEFS+ family with an SCN1A mutation. 62
Long QT syndrome-associated mutations in intrauterine fetal death. 61
Condizioni cliniche associate ad anomalie dell'intervallo QT: Implicazioni cliniche [Clinical conditions associated with abnormal QT interval: clinical implications]. 60
Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms. 60
QTc behavior during exercise and genetic testing for the long-QT syndrome. 59
Ion channel diseases in children: manifestations and management. 59
Brugada and Long QT Syndrome are two different diseases: True or False? 59
Functional characterization and molecular correction of the LQT2 KCNH2-Q376 splicing mutation. Therapeutic implications? 58
Gene symbol: KCNH2. 58
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome. 57
Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. 57
Response to Letters Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation" 57
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. 56
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5. 56
High efficacy of beta-blockers in Long QT Syndrome type 1: contribution of non-compliance and QT-prolonging drugs to the occurrence of beta-blocker treatment “failures”. 56
The Long QT Syndrome 55
Gene expression and arrhythmic risk. 55
Gene symbol: KCNH2 55
Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients. 55
A Refined Multiscale Self-Entropy Approach for the Assessment of Cardiac Control Complexity: Application to Long QT Syndrome Type 1 Patients 55
Gene symbol: KCNH2. 54
Congenital long QT and short QT syndromes 54
Idiopathic Ventricular Fibrillation 54
Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome. 54
Gene symbol: KCNQ1 54
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 54
The genetics underlying acquired long QT syndrome: impact for genetic screening. 54
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 54
Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel. 53
Novel calmodulin mutations associated with congenital arrhythmia susceptibility. 53
Gene symbol: KCNH2 53
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 53
Impact of clinical and genetic findings on the management of young patients with Brugada syndrome. 53
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 53
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 53
Sindrome di Brugada 52
Drug-induced long QT syndrome and exome sequencing: Chinese shadows link past and future. 52
Torsades de Pointes following Acute Myocardial Infarction: Evidence for a Deadly Link with a Common Genetic Variant. 51
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 51
Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1? 51
Mutation-specific risk in two genetic forms of type 3 long QT syndrome. 50
Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome. 50
Refined multiscale entropy analysis of heart period and QT interval variabilities in long QT syndrome type-1 patients2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 50
Filtering approach based on empirical mode decomposition improves the assessment of short scale complexity in long QT syndrome type 1 population 50
Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation 50
Gene symbol: KCNQ1. 50
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 50
Sudden cardiac death in infancy: Focus on prolonged repolarization 49
Gene symbol: KCNQ1. 49
Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1 49
The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge. 48
Reply to the Editor--Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients. 48
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 47
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation 47
NOS1AP Is a Genetic Modifier of the Long-QT Syndrome 46
Ion channels and beating heart: the players and the music 46
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 46
Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION) 46
Congenital Short QT Syndrome 45
Gain of function mutation, S422L, in the KCNJ8-encoded cardiac K ATP channel Kir6.1 as a pathogenic substrate for J wave syndromes 45
Response by Crotti et al to Letter Regarding Article, "Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3' Untranslated Region of KCNQ1?" 45
Molecular basis of atrial fibrillation 44
The Common Long QT Syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. 44
Long QT syndrome: from genetic basis to treatment 44
Gene symbol: SCN5A 44
Symbolic analysis of heart period and QT interval variabilities in LQT1 patients 44
Totale 6.066
Categoria #
all - tutte 32.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.606


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020438 0 0 0 0 0 85 9 97 13 113 117 4
2020/2021708 84 63 16 74 15 91 7 138 20 99 88 13
2021/2022577 13 5 33 7 13 18 7 43 34 6 90 308
2022/20232.247 232 152 27 246 194 221 2 108 907 6 124 28
2023/2024820 92 136 22 53 73 196 23 77 5 30 65 48
2024/2025501 45 178 65 51 46 116 0 0 0 0 0 0
Totale 7.608